BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22902658)

  • 1. Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agents.
    Wadsworth H; Jones PA; Chau WF; Durrant C; Morisson-Iveson V; Passmore J; O'Shea D; Wynn D; Khan I; Black A; Avory M; Trigg W
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5795-800. PubMed ID: 22902658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the structure-activity relationship of a novel tetracyclic class of TSPO ligands-potential novel positron emitting tomography imaging agents.
    O'Shea D; Ahmad R; Årstad E; Avory M; Chau WF; Durrant C; Hirani E; Jones PA; Khan I; Luthra SK; Mantzilas D; Morisson-Iveson V; Passmore J; Robins EG; Shan B; Wadsworth H; Walton S; Zhao Y; Trigg W
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2368-72. PubMed ID: 23489633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new (18)F-labelled acetamidobenzoxazolone-based radioligands for imaging of the translocator protein (18 kDa, TSPO) in the brain.
    Tiwari AK; Fujinaga M; Yui J; Yamasaki T; Xie L; Kumata K; Mishra AK; Shimoda Y; Hatori A; Ji B; Ogawa M; Kawamura K; Wang F; Zhang MR
    Org Biomol Chem; 2014 Dec; 12(47):9621-30. PubMed ID: 25339090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO).
    Wadsworth H; Jones PA; Chau WF; Durrant C; Fouladi N; Passmore J; O'Shea D; Wynn D; Morisson-Iveson V; Ewan A; Thaning M; Mantzilas D; Gausemel I; Khan I; Black A; Avory M; Trigg W
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1308-13. PubMed ID: 22244939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]FEBMP: Positron Emission Tomography Imaging of TSPO in a Model of Neuroinflammation in Rats, and in vitro Autoradiograms of the Human Brain.
    Tiwari AK; Ji B; Yui J; Fujinaga M; Yamasaki T; Xie L; Luo R; Shimoda Y; Kumata K; Zhang Y; Hatori A; Maeda J; Higuchi M; Wang F; Zhang MR
    Theranostics; 2015; 5(9):961-9. PubMed ID: 26155312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and structure-activity relationships of novel benzoxazolone derivatives as 18 kDa translocator protein (TSPO) ligands.
    Fukaya T; Kodo T; Ishiyama T; Kakuyama H; Nishikawa H; Baba S; Masumoto S
    Bioorg Med Chem; 2012 Sep; 20(18):5568-82. PubMed ID: 22884355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images.
    Damont A; Médran-Navarrete V; Cacheux F; Kuhnast B; Pottier G; Bernards N; Marguet F; Puech F; Boisgard R; Dollé F
    J Med Chem; 2015 Sep; 58(18):7449-64. PubMed ID: 26280386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
    Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
    Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline.
    Buck JR; McKinley ET; Hight MR; Fu A; Tang D; Smith RA; Tantawy MN; Peterson TE; Colvin D; Ansari MS; Baldwin RM; Zhao P; Guleryuz S; Manning HC
    J Nucl Med; 2011 Jan; 52(1):107-14. PubMed ID: 21149488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
    James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M
    J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carborane-conjugated 2-quinolinecarboxamide ligands of the translocator protein for boron neutron capture therapy.
    Cappelli A; Valenti S; Mancini A; Giuliani G; Anzini M; Altieri S; Bortolussi S; Ferrari C; Clerici AM; Zonta C; Carraro F; Filippi I; Giorgi G; Donati A; Ristori S; Vomero S; Concas A; Biggio G
    Bioconjug Chem; 2010 Dec; 21(12):2213-21. PubMed ID: 21087014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationship of novel tricyclic benzimidazolone derivatives as potent 18 kDa translocator protein (TSPO) ligands.
    Fukaya T; Kodo T; Ishiyama T; Nishikawa H; Baba S; Masumoto S
    Bioorg Med Chem; 2013 Mar; 21(5):1257-67. PubMed ID: 23352481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptor.
    Jackson A; Guilbert BB; Plant SD; Goggi J; Battle MR; Woodcraft JL; Gaeta A; Jones CL; Bouvet DR; Jones PA; O'Shea DM; Zheng PH; Brown SL; Ewan AL; Trigg W
    Bioorg Med Chem Lett; 2013 Feb; 23(3):821-6. PubMed ID: 23265897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[
    Tang D; Li J; Nickels ML; Huang G; Cohen AS; Manning HC
    Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
    Yanamoto K; Kumata K; Yamasaki T; Odawara C; Kawamura K; Yui J; Hatori A; Suzuki K; Zhang MR
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1707-10. PubMed ID: 19217778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
    Tang D; Nickels ML; Tantawy MN; Buck JR; Manning HC
    Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging and quantitative analysis of TSPO in rat peripheral tissues using small-animal PET with [18F]FEDAC.
    Yanamoto K; Kumata K; Fujinaga M; Nengaki N; Takei M; Wakizaka H; Hosoi R; Momosaki S; Yamasaki T; Yui J; Kawamura K; Hatori A; Inoue O; Zhang MR
    Nucl Med Biol; 2010 Oct; 37(7):853-60. PubMed ID: 20870161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa).
    Hatori A; Yui J; Yamasaki T; Xie L; Kumata K; Fujinaga M; Yoshida Y; Ogawa M; Nengaki N; Kawamura K; Fukumura T; Zhang MR
    PLoS One; 2012; 7(9):e45065. PubMed ID: 22984611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents.
    Peng X; Zhang A; Kula NS; Baldessarini RJ; Neumeyer JL
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5635-9. PubMed ID: 15482938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.